Hornum et al
The majority of participants (61.7%) had not previously received glucose-lowering medications
The mediation by GLP-1 receptors of glucagon-induced insulin secretion revisited in GLP-1 receptor knockout mice
The discussion drew on over a decade of Virtas experience prescribing, managing, and deprescribing GLP-1s and covered everything from long-term efficacy and deprescription to benefit design, cost management, and the future of GLP-1 access
Pyykk JE, Hinnen C, Aydin , Nieuwdorp M, De Brauw LM, Bruin SC, et al
The probiotics beneficial for GLP-1 users often support oral health as a secondary benefit, because the oral and gut microbiomes are interconnected